PODCAST: Brand-name drugs prescribed to Medicare patients cost taxpayers

Far too many doctors in the U.S. prescribe brand-name drugs when generics can be dramatically cheaper.

Boeing’s new 777X airplanes led the Dubai Air Show’s opening day. The company claims orders of roughly $95 billion, purported to be the largest product launch in the history of commercial aviation.

Far too many doctors in the U.S. prescribe brand-name drugs when generics can be dramatically cheaper. When it comes to lower-income Medicare patients, it can be the taxpayer who covers the difference in price -- up to hundreds of millions of dollars a year. ProPublica senior reporter Tracy Weber has been gathering data about the cost of prescription drugs to the taxpayer, and tells Marketplace Morning Report host David Brancaccio what she found.

About the author

David Brancaccio is the host of Marketplace Morning Report. Follow David on Twitter @DavidBrancaccio

Comments

I agree to American Public Media's Terms and Conditions.
With Generous Support From...